CDC25B and breast cancer: CDC25B depletion leads to metformin resistance and PP2A inhibition overcomes the resistance to metformin in breast cancer patient derived organoid models, suggesting that CDC25B–PP2A–AMPK axis is an important regulator of breast cancer growth, AMPK activation and metformin response.